Preoperative high dose rate brachytherapy for rectal cancer (IPG201)
Fast, easy summary view of NICE guidance on 'colorectal cancer'
The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on preoperative high dose rate brachytherapy for rectal cancer in December 2006. In accordance with the Interventional Procedures Programme Process Guide, guidance on procedures with special arrangements are reviewed 3 years after publication and the procedure is reassessed if important new evidence is available.
The guidance was considered for reassessment in October 2010 and it was concluded that NICE will not be updating this guidance at this stage. However, if you believe there is new evidence which should warrant a review of our guidance, please contact us via the email address below.
Rectal cancer is a common form of bowel cancer. Preoperative high dose rate brachytherapy involves placing radioactive material in or close to the tumour to shrink it before surgery.
X65.2 Delivery of a fraction of intracavitary radiotherapy
Note: Use a subsidiary code to identify introduction of radioactive material (Y35, Y36)
Y35.8 Other specified introduction of removable radioactive material into organ NOC
In addition the ICD-10 code C20.X Malignant neoplasm of rectum orC78.5 Secondary malignant neoplasm of large intestine and rectum is assigned
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG201 Preoperative high dose rate brachytherapy for rectal cancer: guidance (web format)
- IPG201 Preoperative high dose rate brachytherapy for rectal cancer: guidance
- IPG201 Treatment of rectal cancer with preoperative high dose rate brachytherapy: Understanding NICE guidance
- IPG201 Treatment of rectal cancer with preoperative high dose rate brachytherapy: Understanding NICE guidance (MS Word format)
- IPG201 Preoperative high dose rate brachytherapy for rectal cancer: Audit criteria
- Preoperative high dose rate brachytherapy for rectal cancer (interventional procedures consultation)
- Preoperative high dose rate brachytherapy for rectal cancer (interventional procedures overview)
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: colorectal cancer
This page was last updated: 15 June 2012
- Web format
- Full Guidance (PDF)
- IPG201 Trin canser y rectwm gyda bracitherapi cyfradd dogn uchel cyndriniaethol: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.